BOSTON, May 28, 2025 -- Aktis Oncology, Inc., an oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuticals for patient populations not addressed by existing platform technologies, today announced...
Art Pappas to moderate panel, "Accessing Capital through Risk-Sharing Models between Early-Stage Companies and Contract Research Organizations" at BIO 2010 in Chicago, IL
News | 05. 05. 2010
